Critical Care Research and Practice / 2021 / Article / Tab 1

Research Article

Outcomes of Patients with Malignancy Admitted to the Intensive Care Units: A Prospective Study

Table 1

Patient characteristics and ICU stay.

Patient characteristics

Number of patients, N272

Age, yr.
 Mean64.25

Type of malignancy, n (%)
 Lung cancer46 (16.9%)
 Leukemia42 (15.4%)
 Lymphoma37 (13.6%)
 Others147 (54.1%)

Stage, n (%)
 Solid and hematologic tumors other than leukemia
  Low-intermediate (stages I–III)49 (22.8%)
  High (stage IV)166 (77.2%)
 Leukemia
  Low or intermediate risk12 (30.8%)
  High risk27 (69.2%)

Malignancy status, n (%)
 Controlled198 (73.9%)
 Uncontrolled70 (26.1%)

Aim of treatment, n (%)
 Curative160 (60.6%)
 Palliative104 (39.4%)

Reason for ICU admission, n (%)
 Sepsis147 (54%)
 Respiratory failure90 (33.1%)
 Altered general status20 (74%)
 Hemorrhagic shock15 (5.5%)

Mode of admission, n (%)
 Through ED180 (66.2%)
 Transfer from floor92 (33.8%)

Laboratory values, n (%)
 Anemia226 (83.1%)
 Leukopenia58 (21.3%)
 Thrombocytopenia107 (39.3%)
 Renal impairment103 (38.1%)

ICU complications, n (%)
 Sepsis226 (83.1%)
 Invasive fungal infection20 (7.4%)
 ARDS63 (23.2%)
 AKI152 (55.9%)
 MOF94 (34.7%)

ICU care, n (%)
 Mechanical ventilation157 (57.7%)
 Vasopressor use185 (68%)
 Antibiotic use266 (97.8%)
 Dialysis45 (16.5%)

ICU length of stay, day
 Mean14
 Median (range)7 (1–153)

According to Rai classification.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.